Time to update your status, Facebook

Published 27-JUL-2018 14:23 P.M.

|

5 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Facebook, Inc. (NASDAQ:FB) is used to hitting it out of the park, but after delivering poor sales and user growth figures it was hit for six as the largest ever loss by market capitalisation of value in one day for a US traded company unfolded.

The company’s shares plummeted from US$217.50 to a low of US$173.75 before closing just above its intraday low.

To put this in perspective, the company’s shares are now trading broadly in line with where they were 12 months ago.

To put this in perspective, the company’s shares are now trading broadly in line with where they were 12 months ago. Note that the NASDAQ index has increased from about 6380 points to 7900 points in the last 12 months, representing an uptick of nearly 25 per cent.

The past performance of this product is not and should not be taken as an indication of future performance. Caution should be exercised in assessing past performance. This product, like all other financial products, is subject to market forces and unpredictable events that may adversely affect future performance.

That gives you an idea of the level of underperformance against its peers that is now implied by its share price.

However, there are still those that believe in the stock.

WATCH: This is what the experts are saying.

Zuckerberg takes US$16 billion hit

A massive US$124 billion in value was decimated, and chief executive Mark Zuckerberg took a hit of circa US$16 billion. Not only did Facebook record a poor operating performance, the company also flagged lower profit margins in coming years.

While it is easy to be wise after the event, it could be argued that the company’s valuation should have been questioned much earlier.

As indicated in RBC Capital Markets, based on its share price of US$217.50 prior to the fall, Facebook was trading on a fiscal 2017 price-earnings (PE) multiple of 40 relative to the company’s 2017 earnings per share.

The lower PE of 32 relates to the multiple following the sharp fall in the company’s shares.

In broad terms, PE multiples should roughly align with the percentage of growth being delivered — a company trading on a PE of 40 should be delivering annual growth in the order of 40 per cent.

Not only were Facebook’s earnings not growing at a rate of 40 per cent per annum, but the signs that growth could be slowing became evident over the last 12 months.

However, a key indicator in any consumer sales industry is year-on-year growth as this tends to take into account seasonal factors and other external issues. Facebook's year-on-year growth has been on the decline since the second quarter of 2017.

RBC suggests this is a buying opportunity

While the data appears worrying, RBC Capital Markets analyst Mark Mahaney’s commented that recommendation and earnings revisions suggest this is a buying opportunity.

It should be noted that broker projections and price targets are only estimates and may not be met. Those considering this stock should seek independent financial advice.

In fact, Mahaney went as far as to say, ‘This likely constitutes one of the best entry points you can get on Facebook’.

He made several points in justifying why investors should not ‘unfriend’ Facebook, and while some of these may get a "LOL" response they are worth considering.

He notes that Facebook still owns two of the largest media assets in the world in Facebook and Instagram.

The group also owns the two largest messaging assets in the world in Messenger & WhatsApp. He said that RBC’s checks and management’s commentary suggest no material change in marketer views of the attractiveness of Facebook’s platforms.

He also believes that monetisation of core Facebook and Instagram assets still has material upside potential and what’s more, Messenger & WhatsApp remain unmonetized. Mahaney highlighted that Facebook’s aggressive investments are improving platform security and creating future revenue streams.

In conclusion, he underlined that even under pressure, Facebook has delivered impressive revenue growth.

On this basis, Mahaney has only downgraded his price target from US$250 to US$225, while maintaining an outperform rating on the stock.

Again, broker projections and price targets are only estimates and may not be met. Those considering this stock should seek independent financial advice.

It's the margins and the bottom line that are alarming

However, it isn’t so much revenue growth that investors are now worried about — it’s more about earnings.

On this note, Facebook executives have predicted that the company would face lower profit margins for more than two years with Zuckerberg noting that heavy investment in security would impact profitability.

Looking at the broader market reaction the news sent shockwaves through the investment community with the Sydney Morning Herald noting, “At least 16 brokerages cut their price targets on Facebook after Chief Financial Officer David Wehner on Wednesday night startled an otherwise routine call with analysts by saying the company faced a multi-year squeeze on its profit margins”.

Multiply 16 brokers by their number of advisors, by their number of individual clients, and it would seem that the stock could remain out of favour for some time.

This article is General Information and contains only some information about some elements of one or more financial products. It may contain; (1) broker projections and price targets that are only estimates and may not be met, (2) historical data in terms of earnings performance and/or share trading patterns that should not be used as the basis for an investment as they may or may not be replicated. Those considering engaging with any financial product mentioned in this article should always seek independent financial advice from a licensed financial advisor before making any financial decisions.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X